Allogene Therapeutics Inc (ALLO) short interest & short volume · 34.0% of float short
Allogene Therapeutics Inc official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.
What changed
ALLO short interest fell 4.0% to 53.4M shares in the Oct 15, 2026 report (34.0% of float, 9.3 days to cover). Daily short volume averaged 33.5% of volume over the last 20 sessions, down from 54.9% the 20 sessions before, the 36th percentile of its own 20-day averages since Sep 22, 2025.
Short interest
Official, twice monthly · settled Oct 15, 2026
- Shares short
- 53.4M
- prior 55.6M
- % of float
- 34.0%
- float 157.2M
- Days to cover
- 9.3
- avg vol 5.8M
- Change vs prior report
- -4.0%
Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.
% of float uses the current float for every report (no float was stored with older reports).
Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026
Daily short volume
Share of each day's volume sold short · FINRA Reg SHO
- Latest (Nov 2)
- 30.8%
- 1.7M of 5.7M
- 20-day average
- 33.5%
- prior 54.9%
- Percentile vs own history
- 36th
- 233 periods since 2025
Loading prices…
Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026
Short squeeze score (model)
Price since settlement: -16.4%
Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.
ALLO's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr
Market-wide: most shorted stocks, biggest changes and unusual short volume · ALLO overview
| Date | Short | Total | Short % of volume |
|---|---|---|---|
| 2026-11-02 | 1,743,936 | 5,663,616 | 30.8% |
| 2026-10-30 | 1,070,196 | 7,536,246 | 14.2% |
| 2026-10-29 | 790,653 | 4,429,920 | 17.9% |
| 2026-10-28 | 1,241,371 | 5,384,382 | 23.1% |
| 2026-10-27 | 2,716,904 | 9,954,650 | 27.3% |
| 2026-10-26 | 1,988,441 | 6,273,941 | 31.7% |
| 2026-10-23 | 2,226,352 | 5,333,040 | 41.8% |
| 2026-10-22 | 1,491,424 | 4,306,247 | 34.6% |
| 2026-10-21 | 1,329,257 | 2,838,513 | 46.8% |
| 2026-10-20 | 985,278 | 2,313,036 | 42.6% |
Healthcare peers with similar quant ratings
ALLO is rated 2.31 of 5 among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works
- ALXO short interest2.34 · Sell · stock
- CBLL short interest2.33 · Sell · stock
- IDYA short interest2.33 · Sell · stock
- PRLD short interest2.32 · Sell · stock
- KYMR short interest2.30 · Sell · stock
- TFX short interest2.30 · Sell · stock
- ENOV short interest2.29 · Sell · stock
- SPRB short interest2.28 · Sell · stock
ALLO short interest FAQ
What is ALLO's short interest?
Allogene Therapeutics Inc (ALLO) had 53.4M shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 34.0% of its 157.2M-share float.
How many days to cover does ALLO have?
9.3 days: 53.4M shares short divided by an average daily volume of 5.8M for the Oct 15, 2026 period.
Is ALLO short interest rising or falling?
ALLO short interest fell (-4.0%) from 55.6M to 53.4M shares in the Oct 15, 2026 report.
Is ALLO a short squeeze candidate?
Lician's squeeze watch scores ALLO 63 out of 100 (elevated) from the Oct 15, 2026 report: short interest % of float 40/40, days to cover 23.1/25, change in short interest vs prior report 0/15, price change since settlement date 0/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.
What share of ALLO daily volume is sold short?
33.5% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 36th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.
What was ALLO's latest FINRA short volume?
On Nov 2, 2026, cached FINRA short volume for Allogene Therapeutics Inc (ALLO) was 1,743,936 shares, 30.8% of 5,663,616 total volume.
How many ALLO short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Allogene Therapeutics Inc (ALLO), from Oct 20, 2026 through Nov 2, 2026.
How did ALLO short volume percent change from the prior cached session?
Cached FINRA short volume for Allogene Therapeutics Inc (ALLO) moved from 14.2% on Oct 30, 2026 to 30.8% on Nov 2, 2026, up 16.6 percentage points.
Not investment advice. Figures as filed or reported, not a live feed.